| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 09/19/2002 | WO2002072822A2 Als2 gene and amyotrophic lateral sclerosis type 2 |
| 09/19/2002 | WO2002072821A2 Method for indentification of cdnas encoding signal peptides |
| 09/19/2002 | WO2002072819A1 Promoters |
| 09/19/2002 | WO2002072817A1 Novel protein, gene encoding the same and method of using the same |
| 09/19/2002 | WO2002072808A1 Methods of screening for introduction of dna into a target cell |
| 09/19/2002 | WO2002072794A2 Immunoglobulin superfamily proteins |
| 09/19/2002 | WO2002072792A2 Heterologous fusion protein constructs comprising a leishmania antigen |
| 09/19/2002 | WO2002072790A2 Tsg101-gag interaction and use thereof |
| 09/19/2002 | WO2002072777A2 A novel antagonistic yeast useful in controlling spoilage of agricultural produce, methods of use thereof and compositions containing same |
| 09/19/2002 | WO2002072771A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 09/19/2002 | WO2002072769A2 Human serpin polypeptides |
| 09/19/2002 | WO2002072759A2 Method to screen peptide display libraries using minicell display |
| 09/19/2002 | WO2002072758A2 Cytochrome p450s and uses thereof |
| 09/19/2002 | WO2002072634A2 Recombinant proteinase k |
| 09/19/2002 | WO2002072632A2 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof. |
| 09/19/2002 | WO2002072630A2 Nucleic acid-associated proteins |
| 09/19/2002 | WO2002072626A2 Novel form of the phgpx protein as a diagnostic marker for male infertility |
| 09/19/2002 | WO2002072625A1 The preparation and usage of plasmodium fusion antigen |
| 09/19/2002 | WO2002072607A2 Soluble heterodimeric cytokine receptor |
| 09/19/2002 | WO2002072605A2 Expression technology for proteins containing a hybrid isotype antibody moiety |
| 09/19/2002 | WO2002072596A1 Steap-related protein |
| 09/19/2002 | WO2002072142A2 Modulation of a balance between the gut mucosal immune system and the intestinal microflora |
| 09/19/2002 | WO2002072089A2 Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereof |
| 09/19/2002 | WO2002055532A3 Variant growth hormone molecules conjugated with macromolecular compounds |
| 09/19/2002 | WO2002050311A3 Lactobacillus strain producing levan and its use in human or pet food products |
| 09/19/2002 | WO2002048381A3 Method for producing biomass |
| 09/19/2002 | WO2002042442A3 Yeast strain for consumption |
| 09/19/2002 | WO2002040746A3 Preventing corrosion with beneficial biofilms |
| 09/19/2002 | WO2002033119A9 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 09/19/2002 | WO2002033079A3 Human g-protein coupled receptor and uses thereof |
| 09/19/2002 | WO2002022871A3 Polymorphic bone morphogenetic protein 2 |
| 09/19/2002 | WO2002022825A9 The c. albicans tec1 gene (catec1) and the coded tec1p protein |
| 09/19/2002 | WO2002018553A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/19/2002 | WO2002017949A9 Novel functions for dp214 |
| 09/19/2002 | WO2002014355A3 Novel mitogen activated kinase |
| 09/19/2002 | WO2002012456A3 Ampk-related serine/threonine kinase, designated snark |
| 09/19/2002 | WO2002010382A9 Trp8, trp9 and trp10, markers for cancer |
| 09/19/2002 | WO2002006452A3 Cloning, sequencing and expression of a comamonas cyclopentanone 1,2-monooxygenase-encoding gene in escherichia coli |
| 09/19/2002 | WO2002002610A3 Secretion and trafficking molecules |
| 09/19/2002 | WO2001090188A9 Receptor-based interaction trap |
| 09/19/2002 | WO2001085956A3 Lipid metabolism enzymes |
| 09/19/2002 | WO2001083514A3 Nucleic acids encoding a regulator of a g protein signaling, rgs18, and uses thereof |
| 09/19/2002 | WO2001081379A3 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 09/19/2002 | WO2001030843A9 Ligand activated transcriptional regulator proteins |
| 09/19/2002 | WO2001014579A9 Compositions and methods for delivery of an agent using attenuated salmonella containing phage |
| 09/19/2002 | WO2001007483A9 Prognosis and therapy of malignant diseases by antibodies which bind phosphorylated met protein |
| 09/19/2002 | WO1997046589A3 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods |
| 09/19/2002 | US20020133001 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 09/19/2002 | US20020133000 Neuronal protein for use in inducing sleep and for treatment of sleep disorders |
| 09/19/2002 | US20020132981 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/19/2002 | US20020132978 VEGF-modulated genes and methods employing them |
| 09/19/2002 | US20020132785 Diagnosis and treatment of cancer or a cellular proliferation and/or differentiation or hematopoietic disorder; evaluation of the efficacy of cancer treatments |
| 09/19/2002 | US20020132775 Human potassium channel 1 and 2 proteins |
| 09/19/2002 | US20020132768 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/19/2002 | US20020132348 New yeast-bacteria shuttle vector |
| 09/19/2002 | US20020132330 Polypeptide for use in the treatment, prevention and diagnosis of inflammation, cell proliferation and apoptosis |
| 09/19/2002 | US20020132329 ELL2, a new member of an ELL family of RNA polymerase II elongation factors |
| 09/19/2002 | US20020132327 Method for identifying proteases, protease target sites and regulators of protease activity in cells |
| 09/19/2002 | US20020132324 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/19/2002 | US20020132323 Nucleotide sequences coding for the PTSI protein |
| 09/19/2002 | US20020132319 Peptide mutant of human ERAB or HADH2, its X-ray crystal structure, and materials and method for identification of inhibitors thereof |
| 09/19/2002 | US20020132312 Removing gases from preferential zones; obtain cells, induce cells to float, harvest cells, crosslink, cells, remove gas |
| 09/19/2002 | US20020132311 Converting glycerol to 1,3-propanediol in thermophilic microorganisms; obtain microorganismal culture, incubate with glycerol, recover 1,3-propanediol |
| 09/19/2002 | US20020132306 Premature antihemopliic factor; for use in the treatment of blood disorders |
| 09/19/2002 | US20020132299 Production of proteins by cell culture |
| 09/19/2002 | US20020132297 Nucleotide sequences coding protein for use in the treatment nflammatory bowel disease, sepsis, viral diseases and rheumatoid arthritis |
| 09/19/2002 | US20020132296 Human Ste20-like stress activated serine/threonine kinase |
| 09/19/2002 | US20020132295 Enzymes having transaminase and aminotransferase activity and methods of use thereof |
| 09/19/2002 | US20020132285 Nutrient broth for use in the detection of antibiotic resistant microorganisms |
| 09/19/2002 | US20020132262 Nucleotide sequences coding tumor suppressor protein for use in the diagnosis and treatment of cancer |
| 09/19/2002 | US20020132255 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of breast cancer |
| 09/19/2002 | US20020132126 Preventing corrosion with beneficial biofilms |
| 09/19/2002 | US20020131980 Comprises an immunizing amount of Mycoplasma hyopneumoniae bacterin, an adjuvant mixture comprising an acrylic acid polymer, a metabolizable oil, a polyoxyethylene polypropylene block copolymer, and an pharmaceutically acceptable carrier |
| 09/19/2002 | US20020131967 Such as melphalan and an anti-interleukin-6 receptor antibody, administering in synergistic amounts |
| 09/19/2002 | US20020131956 Adeno-associated virus vectors encoding factor VIII and methods of using the same |
| 09/19/2002 | US20020131940 Carotenoid preparation |
| 09/19/2002 | US20020130050 Apparatus and method for enhanced biomass production with electrical waveform shaping |
| 09/19/2002 | DE10113011A1 Fermentative production of L-amino acids, useful especially in animal nutrition, by fermenting Coryneform bacteria in which fructose-bisphosphate aldolase gene in weakened |
| 09/19/2002 | DE10112401A1 Alkohol-Dehydrogenase und deren Verwendung Alcohol dehydrogenase and the use thereof |
| 09/19/2002 | DE10112102A1 Verfahren zur fermentativen Herstellung von D-Pantothensäure und/oder deren Salzen A process for the fermentative preparation of D-pantothenic acid and / or salts thereof |
| 09/19/2002 | DE10112100A1 Verfahren zur fermentativen Herstellung von D-Pantothensäure und/oder deren Salzen A process for the fermentative preparation of D-pantothenic acid and / or salts thereof |
| 09/19/2002 | CA2692552A1 Novel protein isolated from pleurotus cornucopiae |
| 09/19/2002 | CA2441495A1 Proteins associated with cell growth, differentiation, and death |
| 09/19/2002 | CA2441082A1 Steap-related protein |
| 09/19/2002 | CA2440649A1 Method to screen peptide display libraries using minicell display |
| 09/19/2002 | CA2440618A1 Immunoglobulin superfamily proteins |
| 09/19/2002 | CA2440576A1 Glucose dehydrogenase |
| 09/19/2002 | CA2440560A1 Methods of screening for introduction of dna into a target cell |
| 09/19/2002 | CA2440278A1 Cytochrome p450s and uses thereof |
| 09/19/2002 | CA2440221A1 Expression technology for proteins containing a hybrid isotype antibody moiety |
| 09/19/2002 | CA2440136A1 Increase in the vitamin e content in organisms due to an increase in the tyrosine aminotransferase activity |
| 09/19/2002 | CA2439853A1 Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereof |
| 09/19/2002 | CA2439702A1 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof |
| 09/19/2002 | CA2439637A1 Human serpin polypeptides |
| 09/19/2002 | CA2437963A1 Therapeutic binding molecules |
| 09/19/2002 | CA2437960A1 Als2 gene and amyotrophic lateral sclerosis type 2 |
| 09/19/2002 | CA2437756A1 Nucleic acid-associated proteins |
| 09/19/2002 | CA2435753A1 Renaturation and activation of the proteinase k zmyogen produced in inclusion bodies |
| 09/19/2002 | CA2432190A1 Improved process for converting nitriles to carboxylic acids using nitrilase |
| 09/18/2002 | EP1241263A1 Alcohol dehydrogenase and uses therefor |